CH371454A - Process for the preparation of sulfamyl-3,4-dihydro-1,2,4-benzothiadiazine-1,1-dioxydes - Google Patents

Process for the preparation of sulfamyl-3,4-dihydro-1,2,4-benzothiadiazine-1,1-dioxydes

Info

Publication number
CH371454A
CH371454A CH6978359A CH6978359A CH371454A CH 371454 A CH371454 A CH 371454A CH 6978359 A CH6978359 A CH 6978359A CH 6978359 A CH6978359 A CH 6978359A CH 371454 A CH371454 A CH 371454A
Authority
CH
Switzerland
Prior art keywords
dioxydes
benzothiadiazine
sulfamyl
dihydro
preparation
Prior art date
Application number
CH6978359A
Other languages
German (de)
Inventor
Destevens George
Harvey Werner Lincoln
Original Assignee
Ciba Geigy
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ciba Geigy filed Critical Ciba Geigy
Priority to CH1836359A priority Critical patent/CH380148A/en
Priority to CH1826359A priority patent/CH380147A/en
Priority to CH1856359A priority patent/CH387643A/en
Publication of CH371454A publication Critical patent/CH371454A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D285/00—Heterocyclic compounds containing rings having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by groups C07D275/00 - C07D283/00
    • C07D285/15—Six-membered rings
    • C07D285/16—Thiadiazines; Hydrogenated thiadiazines
    • C07D285/18—1,2,4-Thiadiazines; Hydrogenated 1,2,4-thiadiazines
    • C07D285/20—1,2,4-Thiadiazines; Hydrogenated 1,2,4-thiadiazines condensed with carbocyclic rings or ring systems
    • C07D285/22—1,2,4-Thiadiazines; Hydrogenated 1,2,4-thiadiazines condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • C07D285/24—1,2,4-Thiadiazines; Hydrogenated 1,2,4-thiadiazines condensed with carbocyclic rings or ring systems condensed with one six-membered ring with oxygen atoms directly attached to the ring sulfur atom
    • C07D285/26—1,2,4-Thiadiazines; Hydrogenated 1,2,4-thiadiazines condensed with carbocyclic rings or ring systems condensed with one six-membered ring with oxygen atoms directly attached to the ring sulfur atom substituted in position 6 or 7 by sulfamoyl or substituted sulfamoyl radicals
    • C07D285/28—1,2,4-Thiadiazines; Hydrogenated 1,2,4-thiadiazines condensed with carbocyclic rings or ring systems condensed with one six-membered ring with oxygen atoms directly attached to the ring sulfur atom substituted in position 6 or 7 by sulfamoyl or substituted sulfamoyl radicals with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached in position 3
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D285/00—Heterocyclic compounds containing rings having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by groups C07D275/00 - C07D283/00
    • C07D285/15—Six-membered rings
    • C07D285/16—Thiadiazines; Hydrogenated thiadiazines
    • C07D285/18—1,2,4-Thiadiazines; Hydrogenated 1,2,4-thiadiazines
    • C07D285/20—1,2,4-Thiadiazines; Hydrogenated 1,2,4-thiadiazines condensed with carbocyclic rings or ring systems
    • C07D285/22—1,2,4-Thiadiazines; Hydrogenated 1,2,4-thiadiazines condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • C07D285/24—1,2,4-Thiadiazines; Hydrogenated 1,2,4-thiadiazines condensed with carbocyclic rings or ring systems condensed with one six-membered ring with oxygen atoms directly attached to the ring sulfur atom
    • C07D285/26—1,2,4-Thiadiazines; Hydrogenated 1,2,4-thiadiazines condensed with carbocyclic rings or ring systems condensed with one six-membered ring with oxygen atoms directly attached to the ring sulfur atom substituted in position 6 or 7 by sulfamoyl or substituted sulfamoyl radicals
    • C07D285/30—1,2,4-Thiadiazines; Hydrogenated 1,2,4-thiadiazines condensed with carbocyclic rings or ring systems condensed with one six-membered ring with oxygen atoms directly attached to the ring sulfur atom substituted in position 6 or 7 by sulfamoyl or substituted sulfamoyl radicals with hydrocarbon radicals, substituted by hetero atoms, attached in position 3
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
CH6978359A 1958-03-03 1959-02-19 Process for the preparation of sulfamyl-3,4-dihydro-1,2,4-benzothiadiazine-1,1-dioxydes CH371454A (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
CH1836359A CH380148A (en) 1958-03-03 1959-02-19 Process for the preparation of sulfamyl-3,4-dihydro-1,2,4-benzothiadiazine-1,1-dioxydes
CH1826359A CH380147A (en) 1958-03-03 1959-02-19 Process for the preparation of sulfamyl-3,4-dihydro-1,2,4-benzothiadiazine-1,1-dioxydes
CH1856359A CH387643A (en) 1958-03-03 1959-02-19 Process for the preparation of sulfamyl-3,4-dihydro-1,2,4-benzothiadiazine-1,1-dioxydes

Applications Claiming Priority (10)

Application Number Priority Date Filing Date Title
US71845258A 1958-03-03 1958-03-03
US72724258A 1958-04-09 1958-04-09
US74058258A 1958-06-09 1958-06-09
US75162058A 1958-07-29 1958-07-29
US76448258A 1958-09-29 1958-09-29
DEC0024177 1959-02-27
DEC0024176 1959-02-27
DEC0028409 1959-02-27
DEC0024178 1959-02-27
DEC0028408 1959-02-27

Publications (1)

Publication Number Publication Date
CH371454A true CH371454A (en) 1963-08-31

Family

ID=27579177

Family Applications (4)

Application Number Title Priority Date Filing Date
CH18463A CH387642A (en) 1958-03-03 1959-02-19 Process for the preparation of sulfamyl-3,4-dihydro-1,2,4-benzothiadiazine-1,1-dioxydes
CH18163A CH377365A (en) 1958-03-03 1959-02-19 Process for the preparation of sulfamyl-3,4-dihydro-1,2,4-benzothiadiazine-1,1-dioxydes
CH18063A CH376514A (en) 1958-03-03 1959-02-19 Process for the preparation of sulfamyl-3,4-dihydro-1,2,4-benzothiadiazine-1,1-dioxydes
CH6978359A CH371454A (en) 1958-03-03 1959-02-19 Process for the preparation of sulfamyl-3,4-dihydro-1,2,4-benzothiadiazine-1,1-dioxydes

Family Applications Before (3)

Application Number Title Priority Date Filing Date
CH18463A CH387642A (en) 1958-03-03 1959-02-19 Process for the preparation of sulfamyl-3,4-dihydro-1,2,4-benzothiadiazine-1,1-dioxydes
CH18163A CH377365A (en) 1958-03-03 1959-02-19 Process for the preparation of sulfamyl-3,4-dihydro-1,2,4-benzothiadiazine-1,1-dioxydes
CH18063A CH376514A (en) 1958-03-03 1959-02-19 Process for the preparation of sulfamyl-3,4-dihydro-1,2,4-benzothiadiazine-1,1-dioxydes

Country Status (6)

Country Link
CH (4) CH387642A (en)
DE (4) DE1445007A1 (en)
FR (2) FR1217929A (en)
GB (1) GB861367A (en)
MY (1) MY6200051A (en)
OA (2) OA01178A (en)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3200117A (en) * 1962-10-03 1965-08-10 Hoffmann La Roche Derivatives of 1, 2, 4-benzothiadiazine-7-sulfonamide-1, 1-dioxide
DE2642140C2 (en) * 1976-09-20 1982-10-28 Degussa Ag, 6000 Frankfurt Process for the production of benzoyl cyanide
DE8700284U1 (en) * 1987-01-07 1987-04-30 Ernst Reiner GmbH & Co KG, 7743 Furtwangen Post date stamp
CA2320354A1 (en) * 1998-02-18 1999-08-26 Neurosearch A/S Novel compounds and their use as positive ampa receptor modulators
US6943159B1 (en) 1998-02-18 2005-09-13 Neurosearch A/S Compounds and their use as positive AMPA receptor modulators
AP2005003232A0 (en) 2002-08-19 2005-03-31 Pfizer Prod Inc Combination therapy for hyperproliferative diseases.
US7235543B2 (en) 2003-03-07 2007-06-26 Schering Corporation Substituted azetidinone compounds, processes for preparing the same, formulations and uses thereof
JP4589919B2 (en) 2003-03-07 2010-12-01 シェーリング コーポレイション Substituted azetidinone compounds, their formulations and uses for the treatment of hypercholesterolemia
US7741317B2 (en) 2005-10-21 2010-06-22 Bristol-Myers Squibb Company LXR modulators
US7888376B2 (en) 2005-11-23 2011-02-15 Bristol-Myers Squibb Company Heterocyclic CETP inhibitors
ES2382009T3 (en) 2006-12-01 2012-06-04 Bristol-Myers Squibb Company N - ((3-Benzyl) -2,2- (bis-phenyl -) - propan-1-amine derivatives as CETP inhibitors for the treatment of atherosclerosis and cardiovascular diseases
US8969514B2 (en) 2007-06-04 2015-03-03 Synergy Pharmaceuticals, Inc. Agonists of guanylate cyclase useful for the treatment of hypercholesterolemia, atherosclerosis, coronary heart disease, gallstone, obesity and other cardiovascular diseases
US20100120694A1 (en) 2008-06-04 2010-05-13 Synergy Pharmaceuticals, Inc. Agonists of Guanylate Cyclase Useful for the Treatment of Gastrointestinal Disorders, Inflammation, Cancer and Other Disorders
CA3089569C (en) 2007-06-04 2023-12-05 Synergy Pharmaceuticals Inc. Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders
EP2321341B1 (en) 2008-07-16 2017-02-22 Synergy Pharmaceuticals Inc. Agonists of guanylate cyclase useful for the treatment of gastrointestinal, inflammation, cancer and other disorders
US9616097B2 (en) 2010-09-15 2017-04-11 Synergy Pharmaceuticals, Inc. Formulations of guanylate cyclase C agonists and methods of use
EP2970384A1 (en) 2013-03-15 2016-01-20 Synergy Pharmaceuticals Inc. Agonists of guanylate cyclase and their uses
JP2016514670A (en) 2013-03-15 2016-05-23 シナジー ファーマシューティカルズ インコーポレイテッド Guanylate cyclase receptor agonists in combination with other drugs
CN105143203A (en) 2013-04-17 2015-12-09 辉瑞大药厂 N-piperidin-3-ylbenzamide derivatives for treating cardiovascular diseases
RS65632B1 (en) 2013-06-05 2024-07-31 Bausch Health Ireland Ltd Ultra-pure agonists of guanylate cyclase c, method of making and using same
WO2016055901A1 (en) 2014-10-08 2016-04-14 Pfizer Inc. Substituted amide compounds
WO2020150473A2 (en) 2019-01-18 2020-07-23 Dogma Therapeutics, Inc. Pcsk9 inhibitors and methods of use thereof

Also Published As

Publication number Publication date
OA03826A (en) 1971-12-24
DE1445005A1 (en) 1968-10-24
FR1217929A (en) 1960-05-06
CH377365A (en) 1964-05-15
FR1264468A (en) 1961-06-23
DE1112079B (en) 1961-08-03
DE1445574A1 (en) 1969-01-16
CH376514A (en) 1964-04-15
DE1445008A1 (en) 1968-10-24
OA01178A (en) 1969-01-25
GB861367A (en) 1961-02-22
DE1445007A1 (en) 1968-10-24
MY6200051A (en) 1962-12-31
DE1445006B2 (en) 1975-05-07
CH387642A (en) 1965-02-15
DE1445006A1 (en) 1968-10-24

Similar Documents

Publication Publication Date Title
CH371454A (en) Process for the preparation of sulfamyl-3,4-dihydro-1,2,4-benzothiadiazine-1,1-dioxydes
CH444167A (en) Process for the preparation of 6-trifluoromethyl-7-sulfamyl-3,4-dihydro-1,2,4-benzothiadiazine-1,1-dioxide
CH381696A (en) Process for the preparation of 1,3,4-oxadiazoles
CH379488A (en) Process for the preparation of 1,4-dicyanobutenes
CH392524A (en) Process for the preparation of 3,4-dihydro-1,2,4-benzothiadiazine-1,1-dioxydes
CH382174A (en) Process for the preparation of sulfamyl-3,4-dihydro-1,2,4-benzothiadiazine-1,1-dioxydes
CH383391A (en) Process for the preparation of 1,2,4-benzothiadiazine-1,1-dioxydes
AT254877B (en) Process for the preparation of 7-sulfonamido-3,4-dihydro-1,2,4-benzothiadiazine-1,1-dioxydes
CH396015A (en) Process for the preparation of 3,4-dihydro-1,2,4-benzothiadiazine-1,1-dioxydes
CH389628A (en) Process for the preparation of 2,4-diamino-quinazolines
CH380147A (en) Process for the preparation of sulfamyl-3,4-dihydro-1,2,4-benzothiadiazine-1,1-dioxydes
CH385218A (en) Process for the preparation of 3-substituted 6-trifluoromethyl-7-sulfamyl-3,4-dihydro-1,2,4-benzothiadiazine-1,1-dioxydes
CH405331A (en) Process for the preparation of 3,4-dihydro-1,2,4-benzothiadiazine-1,1-dioxydes
CH381240A (en) Process for the preparation of 3,4-dihydro-1,2,4-benzothiadiazine-1,1-dioxydes
AT216513B (en) Process for the preparation of new 3,4-dihydro-1,2,4-benzothiadiazine-1,1-dioxydes
AT209341B (en) Process for the preparation of 1,3,4-oxdiazoles
CH403781A (en) Process for the preparation of 3,4-dihydro-1,2,4-benzothiadiazine-1,1-dioxide-7-sulfonic acid amides
CH387648A (en) Process for the preparation of 1,9- or 1,10-diaminooctadecane
AT234694B (en) Process for the preparation of new 3,3-disubstituted 7-sulfamyl-3,4-dihydro-1,2,4-benzothiadiazine-1,1-dioxydes
AT216514B (en) Process for the preparation of new 3,4-dihydro-1,2,4-benzothiadiazine-1,1-dioxydes
AT227702B (en) Process for the preparation of new 3,4-dihydro-1,2,4-benzothiadiazine-1,1-dioxydes
AT224641B (en) Process for the preparation of new 3,4-dihydro-1,2,4-benzothiadiazine-1,1-dioxydes
AT223201B (en) Process for the preparation of new 3, 4-dihydro-1, 2, 4-benzothiadiazine-1, 1-dioxydes
AT216515B (en) Process for the preparation of new 3,4-dihydro-1,2,4-benzothiadiazine-1,1-dioxydes
AT252257B (en) Process for the preparation of 7-sulfamyl-3,4-dihydro-1, 2, 4-benzothiadiazine-1, 1-dioxydes